UPDATE : Monday, November 18, 2019
상단여백
Ministry OKs ATGC's p1, 2 trial for BTX
ATGC, a local biopharmaceutical firm, said that the Ministry of Food and Dr...
by Lee Han-soo  |  2019-10-18 18:23
라인
Physicians feel burdened by Ranitidine ban: survey
Nearly half of doctors have encountered difficulties with patients over the...
by Lee Han-soo  |  2019-10-18 16:48
라인
Daewoong launches BTX in Canada
Daewoong Pharmaceutical said that it has launched its botulinum toxin (BTX)...
by Lee Han-soo  |  2019-10-18 14:31
라인
CHA Biotech wins patent for somatic-cloned embryonic stem cell tech
CHA Biotech said it has registered a patent for the method of manufacturing...
by Lee Han-soo  |  2019-10-17 17:59
라인
US sales of Remicade drop due to biosimilar’s rise
U.S. sales of Remicade (ingredient: infliximab), the autoimmune disease tre...
by Jeong Sae-im  |  2019-10-17 13:32
라인
'Eisai's Lenvima extends survival period, improves patients’ quality of life'
Eisai's Lenvima, a hepatocellular carcinoma treatment, has managed to s...
by Lee Han-soo  |  2019-10-16 18:22
라인
‘New drug approval process takes about 300 days in Korea’
A local research team has found that it takes about 300 days for multinatio...
by Lee Han-soo  |  2019-10-16 15:06
라인
Merck Korea forcefully shuts down general medicine biz
Merck Biopharma Korea said it would complete shutting down the General Medi...
by Kim Yun-mi  |  2019-10-15 15:51
라인
Galderma Korea’s key strategy: choice and concentration
Galderma recently debuted as the world’s largest independent dermatology co...
by Kim Yun-mi  |  2019-10-15 13:56
라인
Medytox, Daewoong still in dispute over Nabota's spore appraisal
Medytox and Daewoong Pharmaceutical continued to brawl over the origin of t...
by Lee Han-soo  |  2019-10-15 11:28
라인
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients
The Korean branch of Eli Lilly said it has presented the phase 4 IXORA-R st...
by Lee Han-soo  |  2019-10-14 18:01
라인
HanAll's Chinese partner ends P2 trial of dry eye treatment
HanAll Biopharma said that Harbour Biomed, its Chinese partner, has complet...
by Lee Han-soo  |  2019-10-14 14:08
라인
[Special] How are Korean employees coping with big-pharma M&As?
Since multinational pharmaceutical companies announced merger and acquisiti...
by Kim Yun-mi  |  2019-10-14 13:45
라인
Sanofi releases data showing improved survival for prostate cancer treatment
Sanofi said that it has published research results confirming a longer radi...
by Lee Han-soo  |  2019-10-14 12:16
라인
Regulator keeps Kolon Tissuegene listed with 1-year grace period
The Korean Exchange (KRX) decided to keep Kolon Tissuegene listed on the Ko...
by Lee Han-soo  |  2019-10-12 09:41
라인
GC to market Merck's diabetes treatment
Merck Biopharma Korea said that GC would market Glucophage, its diabetes tr...
by Lee Han-soo  |  2019-10-11 18:13
라인
Bayer drugs out of stock in Korea
Bayer is having trouble supplying its drug in the local market as the compa...
by Lee Han-soo  |  2019-10-11 16:36
라인
Sanofi to cover part of Dupixent cost for atopic dermatitis patients
Sanofi said it would run a program to support part of the cost of Dupixent,...
by Kim Yun-mi  |  2019-10-11 15:13
라인
Takeda Korea’s labor union goes on strike
The conflict between Takeda Korea's management and labor union has reac...
by Lee Han-soo  |  2019-10-11 14:33
라인
Roche’s Tecentriq combo therapy shows encouraging results
Roche Korea said the company had presented results from a phase 1b study ev...
by Lee Han-soo  |  2019-10-10 17:36
여백
여백
여백
Back to Top